Esperion Therapeutics, Inc. (ESPR)
2.57
-0.04
(-1.53%)
USD |
NASDAQ |
Apr 06, 14:44
Esperion Therapeutics EPS Diluted (Quarterly) : 0.2173 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.778 |
| Harrow, Inc. | 0.178 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 61.83M |
| Revenue (Quarterly) | 168.45M |
| Total Expenses (Quarterly) | 106.62M |
| Enterprise Value | 1.050B |
| Gross Profit Margin (Quarterly) | 83.46% |
| Profit Margin (Quarterly) | 36.71% |
| Earnings Yield | -8.15% |
| Operating Earnings Yield | 10.67% |
| Normalized Earnings Yield | -8.152 |